메뉴 건너뛰기




Volumn 272, Issue 2, 2012, Pages 193-199

MUC1 mucin is expressed on human T-regulatory cells: Function in both co-stimulation and co-inhibition

Author keywords

MUC1 mucin; Regulatory T cells; T cells

Indexed keywords

MUCIN 1;

EID: 83955163763     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.10.012     Document Type: Article
Times cited : (17)

References (18)
  • 1
    • 0037097594 scopus 로고    scopus 로고
    • The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor
    • Chambers C.A., Kang J., Wu Y., Held W., Raulet D.H., Allison J.P. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor. Blood 2002, 99:4509-4516.
    • (2002) Blood , vol.99 , pp. 4509-4516
    • Chambers, C.A.1    Kang, J.2    Wu, Y.3    Held, W.4    Raulet, D.H.5    Allison, J.P.6
  • 2
    • 17644401665 scopus 로고    scopus 로고
    • MUC1 mucin-mediated regulation of human T cells
    • Agrawal B., Longenecker B.M. MUC1 mucin-mediated regulation of human T cells. Int. Immunol. 2005, 17:391-399.
    • (2005) Int. Immunol. , vol.17 , pp. 391-399
    • Agrawal, B.1    Longenecker, B.M.2
  • 4
    • 0028148592 scopus 로고
    • Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules
    • Zrihan-Licht S., Baruch A., Elroy-Stein O., Keydar I., Wreschner D.H. Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules. FEBS Lett. 1994, 356:130-136.
    • (1994) FEBS Lett. , vol.356 , pp. 130-136
    • Zrihan-Licht, S.1    Baruch, A.2    Elroy-Stein, O.3    Keydar, I.4    Wreschner, D.H.5
  • 6
    • 0034254301 scopus 로고    scopus 로고
    • CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression
    • Carreno B.M., Bennett F., Chau T.A., Ling V., Luxenberg D., Jussif J., Baroja M.L., Madrenas J. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J. Immunol. 2000, 165:1352-1356.
    • (2000) J. Immunol. , vol.165 , pp. 1352-1356
    • Carreno, B.M.1    Bennett, F.2    Chau, T.A.3    Ling, V.4    Luxenberg, D.5    Jussif, J.6    Baroja, M.L.7    Madrenas, J.8
  • 7
    • 0031914321 scopus 로고    scopus 로고
    • Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2
    • Agrawal B., Krantz M.J., Reddish M.A., Longenecker B.M. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat. Med. 1998, 4:43-49.
    • (1998) Nat. Med. , vol.4 , pp. 43-49
    • Agrawal, B.1    Krantz, M.J.2    Reddish, M.A.3    Longenecker, B.M.4
  • 8
    • 0037385330 scopus 로고    scopus 로고
    • Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
    • Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
    • (2003) Nat. Immunol. , vol.4 , pp. 330-336
    • Fontenot, J.D.1    Gavin, M.A.2    Rudensky, A.Y.3
  • 9
    • 33847414082 scopus 로고    scopus 로고
    • Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood
    • Ahn J.S., Krishnadas D.K., Agrawal B. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Int. Immunol. 2007, 19:227-237.
    • (2007) Int. Immunol. , vol.19 , pp. 227-237
    • Ahn, J.S.1    Krishnadas, D.K.2    Agrawal, B.3
  • 10
    • 0032531005 scopus 로고    scopus 로고
    • Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation
    • Agrawal B., Krantz M.J., Parker J., Longenecker B.M. Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation. Cancer Res. 1998, 58:4079-4081.
    • (1998) Cancer Res. , vol.58 , pp. 4079-4081
    • Agrawal, B.1    Krantz, M.J.2    Parker, J.3    Longenecker, B.M.4
  • 11
    • 0033764673 scopus 로고    scopus 로고
    • Advances in interleukin 2 receptor targeted treatment
    • Morris J.C., Waldmann T.A. Advances in interleukin 2 receptor targeted treatment. Ann. Rheum. Dis. 2000, 59(Suppl 1):i109-114.
    • (2000) Ann. Rheum. Dis. , vol.59 , Issue.SUPPL. 1
    • Morris, J.C.1    Waldmann, T.A.2
  • 12
    • 79955629731 scopus 로고    scopus 로고
    • Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitro
    • Huang J., Wang Q.J., Yang S., Li Y.F., El-Gamil M., Rosenberg S.A., Robbins P.F. Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitro. J. Immunother. 2011, 34:327-335.
    • (2011) J. Immunother. , vol.34 , pp. 327-335
    • Huang, J.1    Wang, Q.J.2    Yang, S.3    Li, Y.F.4    El-Gamil, M.5    Rosenberg, S.A.6    Robbins, P.F.7
  • 13
    • 0038106670 scopus 로고    scopus 로고
    • Induction of CD4(+) T cell apoptosis as a consequence of impaired cytoskeletal rearrangement in UVB-irradiated dendritic cells
    • Termeer C.C., Wachter T., Averbeck M., Hara H., Tesmann J.P., Simon J.C., Denfeld R.W. Induction of CD4(+) T cell apoptosis as a consequence of impaired cytoskeletal rearrangement in UVB-irradiated dendritic cells. J. Immunol. 2003, 171:776-782.
    • (2003) J. Immunol. , vol.171 , pp. 776-782
    • Termeer, C.C.1    Wachter, T.2    Averbeck, M.3    Hara, H.4    Tesmann, J.P.5    Simon, J.C.6    Denfeld, R.W.7
  • 14
    • 33845698625 scopus 로고    scopus 로고
    • The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells
    • Yi H., Zhen Y., Jiang L., Zheng J., Zhao Y. The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells. Cell. Mol. Immunol. 2006, 3:189-195.
    • (2006) Cell. Mol. Immunol. , vol.3 , pp. 189-195
    • Yi, H.1    Zhen, Y.2    Jiang, L.3    Zheng, J.4    Zhao, Y.5
  • 16
    • 0344153890 scopus 로고    scopus 로고
    • CD4(+)/CD25(+) regulatory cells inhibit activation of tumor-primed CD4(+) T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination
    • Lasarte J.J., Casares N., Arribillaga L., Sarobe P., Dotor J., de Cerio A.L.D., Melero I., Prieto J., Borras-Cuesta F. CD4(+)/CD25(+) regulatory cells inhibit activation of tumor-primed CD4(+) T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. J. Immunol. 2003, 171:5931-5939.
    • (2003) J. Immunol. , vol.171 , pp. 5931-5939
    • Lasarte, J.J.1    Casares, N.2    Arribillaga, L.3    Sarobe, P.4    Dotor, J.5    de Cerio, A.L.D.6    Melero, I.7    Prieto, J.8    Borras-Cuesta, F.9
  • 17
    • 34547774699 scopus 로고    scopus 로고
    • TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets
    • Pyzik M., Piccirillo C.A. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. J. Leukoc. Biol. 2007, 82:335-346.
    • (2007) J. Leukoc. Biol. , vol.82 , pp. 335-346
    • Pyzik, M.1    Piccirillo, C.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.